Guo-sheng Du
Shenyang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
CD8 regulatory T cells are a novel type regulatory T cells in the induction of transplantation immune tolerance.
Journal: Frontiers in immunology
Published: March 12, 2026
Guideline on application of allogeneic vascular transplantation in abdominal surgery.
Journal: Hepatobiliary & pancreatic diseases international : HBPD INT
Published: August 06, 2025
Rapamycin-modified novel tolerogenic dendritic cells induce liver graft tolerance through MHC-II+CD8+ regulatory T cells.
Journal: Hepatology communications
Published: July 14, 2025
Chinese expert consensus on quantitatively monitoring and assessing immune cell function status and its clinical application (2024 edition).
Journal: Hepatobiliary & pancreatic diseases international : HBPD INT
Published: June 12, 2024
Sirolimus increases the anti-cancer effect of Huai Er by regulating hypoxia inducible factor-1α-mediated glycolysis in hepatocellular carcinoma.
Journal: World journal of gastroenterology
Published: November 10, 2021
PD-L1+NEUT, Foxp3+Treg, and NLR as New Prognostic Marker with Low Survival Benefits Value in Hepatocellular Carcinoma.
Journal: Technology in cancer research & treatment
Published: October 04, 2021
Prognostic Value of Preoperative NLR and Vascular Reconstructive Technology in Patients With Pancreatic Cancer of Portal System Invasion: A Real World Study.
Journal: Frontiers in oncology
Published: March 19, 2021
Trends of rapamycin in survival benefits of liver transplantation for hepatocellular carcinoma.
Journal: World journal of gastrointestinal surgery
Published: February 21, 2021
Rapamycin treated tol-dendritic cells derived from BM-MSCs reversed graft rejection in a rat liver transplantation model by inducing CD8+CD45RC-Treg.
Journal: Molecular immunology
Published: November 27, 2020
Reduction of FoxP3+ Tregs by an immunosuppressive protocol of rapamycin plus Thymalfasin and Huaier extract predicts positive survival benefits in a rat model of hepatocellular carcinoma.
Journal: Annals of translational medicine
Published: May 13, 2020
Novel strategy of sirolimus plus thymalfasin and huaier granule on tumor recurrence of hepatocellular carcinoma beyond the UCSF criteria following liver transplantation: A single center experience.
Journal: Oncology letters
Published: September 24, 2017
Sirolimus treatment for cirrhosis or hepatocellular carcinoma patients accompanied by psoriasis after liver transplantation: A single center experience.
Journal: Oncology letters
Published: February 28, 2017
Last Updated: 09/26/2026